Neurostimulation Devises Market Segmented By Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Strimulation, Vagus Nerve Stimulation, Cochlear Implants, Gastric Electric Stimulation Implantable Devices and Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation External Devices
Industry: Healthcare
Published Date: May-2015
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 98
Report ID: PMRREP2824
Chapter 1. Preface11
1.1. Report Description11
1.2. Research Methodology12
1.3. Assumptions13
Chapter 2. Market Synopsis14
Chapter 3. Porter’s Five Forces Analysis16
3.1. Bargaining Power of Suppliers16
3.2. Bargaining Power of Buyers17
3.3. Threat of New Entrants17
3.4. Threat of Substitutes17
3.5. Intensity of Rivalry18
Chapter 4. Industry Overview19
4.1. Market Definition19
4.2. Market Drivers20
4.2.1. Increasing prevalence of chronic pain20
4.2.2. Rise in incidence of neurological disorders21
4.2.3. Rising awareness about mental diseases and their treatment21
4.2.4. Growing aging population22
4.2.5. Increasing R&D investments in novel and innovative neurostimulation devices developments23
4.2.6. Increasing demand for minimally invasive treatment24
4.3. Impact Analysis of Market Drivers25
4.4. Market Restraints26
4.4.1. Availability of alternative treatment therapies for neurological diseases26
4.4.2. Side-effects of neurostimulation devices26
4.5. Impact Analysis of Market Restraints27
4.6. Opportunities27
4.6.1. Emerging markets hold major potential27
Chapter 5. Global Market Size and Forecast28
Chapter 6. Market Size and Forecast, by Device Type39
6.1. Implantable device39
6.2. External devices41
Chapter 7. Market Size and Forecast, by Implantable Devices44
7.1. Spinal Cord Stimulation44
7.2. Deep Brain Stimulation46
7.3. Sacral Nerve Strimulation48
7.4. Vagus Nerve Stimulation50
7.5. Cochlear Implants52
7.6. Gastric Electric Stimulation54
Chapter 8. Market Size and Forecast, by External Devices57
8.1. Transcutaneous Electrical Nerve Stimulation57
8.2. Transcranial Magnetic Stimulation59
Chapter 9. Market Size and Forecast, by Application62
9.1. Pain Management62
9.2. Parkinson’s Disease64
9.3. Urinary and Fecal Incontinence66
9.4. Epilepsy68
9.5. Hearing loss70
9.6. Gastroparesis72
9.7. Depression74
Chapter 10. Market Size and Forecast, by Geography77
10.1. North America77
10.2. Europe80
10.3. Asia Pacific83
10.4. Rest of the World (RoW)85
Chapter 11. Competitive Scenario88
11.1. Competitive Benchmarking88
Chapter 12. Company Profiles91
12.1. Medtronic plc91
12.1.1. Company overview91
12.1.2. Products and services92
12.1.3. Financial performance93
12.1.4. Key developments93
12.2. St. Jude Medical, Inc.94
12.2.1. Company overview94
12.2.2. Products and services94
12.2.3. Financial performance95
12.2.4. Key developments95
12.3. Boston Scientific Corporation96
12.3.1. Company overview96
12.3.2. Products and services97
12.3.3. Financial performance98
12.3.4. Key developments98
12.4. Cyberonics, Inc.99
12.4.1. Company overview99
12.4.2. Products and services99
12.4.3. Financial performance100
12.4.4. Key developments100
12.5. Cochlear, Ltd.101
12.5.1. Company overview101
12.5.2. Products and services101
12.5.3. Financial performance102
12.5.4. Key developments102
12.6. NeuroPace, Inc.103
12.6.1. Company overview103
12.6.2. Products and services103
12.6.3. Financial performance103
12.6.4. Key developments104
12.7. NeuroSigma, Inc.105
12.7.1. Company overview105
12.7.2. Products and services105
12.7.3. Financial performance105
12.7.4. Key developments106
12.8. NDI Medical, LLC107
12.8.1. Company overview107
12.8.2. Products and services107
12.8.3. Financial performance107
12.8.4. Key developments108
12.9. MED-EL109
12.9.1. Company overview109
12.9.2. Products and services109
12.9.3. Financial performance110
12.9.4. Key developments110
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
List of Tables
TABLE 1: Market snapshot: Neurostimulation devices market, 2014 and 202014
TABLE 2: Drivers for neurostimulation devices market: Impact analysis25
TABLE 3: Restraints for neurostimulation devices market: Impact analysis27
TABLE 4: Global neurostimulation devices market size, by region, 2010 – 2013 (USD million)29
TABLE 5: Global neurostimulation devices market size, by region, 2014 – 2020 (USD million)29
TABLE 6: Global neurostimulation devices market size, by type of devices, 2010 – 2013 (USD million)30
TABLE 7: Global neurostimulation devices market size, by type of device, 2014 – 2020 (USD million)31
TABLE 8: Global neurostimulation devices market, by implantable devices, 2010 – 2013 (USD million)32
TABLE 9: Global neurostimulation devices market, by implantable devices, 2014 – 2020 (USD million)33
TABLE 10: Global neurostimulation devices market, by external devices, 2010 – 2013 (USD million)34
TABLE 11: Global neurostimulation devices market, by external device type, 2014 – 2020 (USD million)35
TABLE 12: Global neurostimulation devices market, by application type, 2010 – 2013 (USD million)37
TABLE 13: Global neurostimulation devices market, by application type, 2014 – 2020 (USD million)38
TABLE 14: Global implantable device market size, by region, 2010 – 2013 (USD million)40
TABLE 15: Global implantable devices market size, by region, 2014 – 2020 (USD million)41
TABLE 16: Global external devices market size, by region, 2010 – 2013 (USD million)42
TABLE 17: Global external devices market size, by region, 2014 – 2020 (USD million)43
TABLE 18: Global SCS market size, by region, 2010 – 2013 (USD million)45
TABLE 19: Global SCS market size, by region, 2014 – 2020 (USD million)45
TABLE 20: Global DBS market size, by region, 2010 – 2013 (USD million)47
TABLE 21: Global DBS market size, by region, 2014 – 2020 (USD million)48
TABLE 22: Global SNS market size, by region, 2010 – 2013 (USD million)49
TABLE 23: Global SNS market size, by region, 2014 – 2020 (USD million)50
TABLE 24: Global VNS market size, by region, 2010 – 2013 (USD million)51
TABLE 25: Global VNS market size, by region, 2014 – 2020 (USD million)52
TABLE 26: Global CI market size, by region, 2010 – 2013 (USD million)53
TABLE 27: Global CI market size, by region, 2014 – 2020 (USD million)54
TABLE 28: Global GES market size, by region, 2010 – 2013 (USD million)55
TABLE 29: Global GES market size, by region, 2014 – 2020 (USD million)56
TABLE 30: Global TENS market size, by region, 2010 – 2013 (USD million)58
TABLE 31: Global TENS market size, by region, 2014 – 2020 (USD million)58
TABLE 32: Global TMS market size, by region, 2010 – 2013 (USD million )60
TABLE 33: Global TMS market size, by region, 2014 – 2020 (USD million)60
TABLE 34: Global pain management market size, by region, 2010 – 2013 (USD )63
TABLE 35: Global pain management market size, by region, 2014 – 2020 (USD million)64
TABLE 36: Global Parkinson’s disease market size, by region, 2010 – 2013 (USD million)65
TABLE 37: Global Parkinson’s disease market size, by region, 2014 – 2020 (USD million)66
TABLE 38: Global urinary and fecal incontinence market size, by region, 2010 – 2013 (USD million)67
TABLE 39: Global urinary and fecal incontinence market size, by region, 2014 – 2020 (USD million)68
TABLE 40: Global epilepsy market size, by region, 2010 – 2013 (USD million)69
TABLE 41: Global epilepsy market size, by region, 2014 – 2020 (USD million)70
TABLE 42: Global hearing loss market size, by region, 2010 – 2013 (USD million)71
TABLE 43: Global hearing loss market size, by region, 2014 – 2020 (USD million)72
TABLE 44: Global gastroparesis market size, by region, 2010 – 2013 (USD million)73
TABLE 45: Global gastroparesis market size, by region, 2014 – 2020 (USD million)74
TABLE 46: Global depression market size, by region, 2010 – 2013 (USD million)75
TABLE 47: Global depression market size, by region, 2014 – 2020 (USD million)76
TABLE 48: North America neurostimulation devices market size, by country, 2010 – 2013 (USD million)79
TABLE 49: North America neurostimulation devices market size, by country, 2014 – 2020 (USD million)80
TABLE 50: Europe neurostimulation devices market size, by country, 2010 – 2013 (USD million)82
TABLE 51: Europe neurostimulation devices market size, by country, 2014 – 2020 (USD million)82
TABLE 52: Asia Pacific neurostimulation devices market size, by country, 2010 – 2013 (USD million)84
TABLE 53: Asia Pacific neurostimulation devices market size, by country, 2014 – 2020 (USD million)85
TABLE 54: RoW neurostimulation devices market size, by country, 2010 – 2013 (USD million)86
TABLE 55: RoW neurostimulation devices market size, by country, 2014 – 2020 (USD million)87
TABLE 56: Product categories of Medtronic plc92
TABLE 57: Product categories of St. Jude Medical, Inc94
TABLE 58: Product categories of Boston Scientific Corporation97
TABLE 59: Product categories of Cyberonics, Inc99
TABLE 60: Product categories of Cochlear, Ltd.101
TABLE 61: Product categories NeuroPace, Inc.103
TABLE 62: Product categories of NeuroSigma, Inc.105
TABLE 63: Product categories of NDI Medical, LLC107
TABLE 64: Product categories of MED-EL109
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
List of Figures
FIG. 1: Neurostimulation devices market: Porter’s five forces analysis16
FIG. 2: Aging population in major countries, 2000 – 2050 (% share of total population)23
FIG. 3: Global neurostimulation devices market share, by region, by value, 201328
FIG. 4: Global neurostimulation devices market share, by type of devices, by value, 201330
FIG. 5: Global neurostimulation devices market share, by implantable devices, by value, 201331
FIG. 6: Global neurostimulation devices market share, by external devices, by value, 201334
FIG. 7: Global neurostimulation devices market share, by application type, by value, 201336
FIG. 8: Global implantable device market share, by region, by value, 201339
FIG. 9: Global external devices market share, by region, by value, 201342
FIG. 10: Global SCS market share, by region, by value 201344
FIG. 11: Global DBS market, by region 2013 (% share)47
FIG. 12: Global SNS market share, by region, by value 201349
FIG. 13: Global VNS market share, by region, by value, 2013 (% share)51
FIG. 14: Global CI market share, by region, by value, 2013 (% share)53
FIG. 15: Global GES market share, by region, by value, 2013 (% share)55
FIG. 16: Global TENS market share, by region, by value, 2013 (% share)57
FIG. 17: Global TMS market share, by region, by value, 201359
FIG. 18: Global pain management market share, by region, by value, 201362
FIG. 19: Global Parkinson’s disease market share, by region, by value, 201365
FIG. 20: Global urinary and fecal incontinence market share, by region, by value, 201367
FIG. 21: Global epilepsy market share, by region, by value, 201369
FIG. 22: Global hearing loss market share, by region, by value, 201371
FIG. 23: Global gastroparesis market share, by region, by value, 201373
FIG. 24: Global depression market share, by region, by value, 201375
FIG. 25: North America neurostimulation devices market share, by country, by value, 2013 (% share)79
FIG. 26: Europea neurostimulation devices market share, by country, by value, 2013 (% share)81
FIG. 27: Asia Pacific neurostimulation devices market share, by country, by value, 2013 (% share)84
FIG. 28: RoW neurostimulation devices market share, by country, by value, 2013 (% share)86
FIG. 29: Leading players and their product offerings in the market88
FIG. 30: Overall market presence and focus on neurostimulation business89
FIG. 31: Sales and net earnings of Medtronic, plc, 2012 – 2014 (USD Million)93
FIG. 32: Net sales and net earnings of St. Jude Medical, Inc, 2011 – 2013 (USD Million)95
FIG. 33: Net sales and net income/loss of Boston Scientific Corporation, 2011 – 2013 (USD Million)98
FIG. 34: Net sales and net income of Cyberonics, Inc, 2011 – 2013 (USD Million)100
FIG. 35: Revenue and net profit of Cochlear, Ltd., 2011 – 2013 (USD million)102
